Gene · 8564
Papers1,472
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,472
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rapid screening for autoimmune diseases using Fourier transform infrared spectroscopy and deep learning algorithms. | Front Immunol | 2023 | 38162641 | PubTator, text mining | PubMed |
| Poorer subjective mental health among girls: Artefact or real? Examining whether interpretations of what shapes mental health vary by sex. | PLoS One | 2023 | 38150447 | PubTator, text mining | PubMed |
| Urine Metabolite Analysis to Identify Pathomechanisms of Long COVID: A Pilot Study. | Int J Tryptophan Res | 2023 | 38144169 | PubTator, text mining | PubMed |
| Metabolic changes with the occurrence of atherosclerotic plaques and the effects of statins. | Front Immunol | 2023 | 38143759 | PubTator, text mining | PubMed |
| Bidirectional Relationship between HIV/HBV Infection and Comorbid Depression and/or Anxiety: A Systematic Review on Shared Biological Mechanisms. | J Pers Med | 2023 | 38138916 | PubTator, text mining | PubMed |
| Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients. | Cells | 2023 | 38132134 | PubTator, text mining | PubMed |
| Stability Studies of Kynurenine Pathway Metabolites in Blood Components Define Optimal Blood Processing Conditions. | Int J Tryptophan Res | 2023 | 38106464 | PubTator, text mining | PubMed |
| On the benefits of the tryptophan metabolite 3-hydroxyanthranilic acid in Caenorhabditis elegans and mouse aging. | Nat Commun | 2023 | 38097593 | PubTator, text mining | PubMed |
| Availability and access to Livelihood capital assets for development of sustainable Livelihood strategies of fishermen: A case study of Manchar Lake Pakistan. | Heliyon | 2023 | 38094069 | PubTator, text mining | PubMed |
| Impact of IDO activation and alterations in the kynurenine pathway on hyperserotonemia, NAD+ production, and AhR activation in autism spectrum disorder. | Transl Psychiatry | 2023 | 38071324 | PubTator, text mining | PubMed |
| Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing. | Int J Mol Sci | 2023 | 38069121 | PubTator, text mining | PubMed |
| Ion Channel Disturbances in Migraine Headache: Exploring the Potential Role of the Kynurenine System in the Context of the Trigeminovascular System. | Int J Mol Sci | 2023 | 38068897 | PubTator, text mining | PubMed |
| Energy metabolic reprogramming regulates programmed cell death of renal tubular epithelial cells and might serve as a new therapeutic target for acute kidney injury. | Front Cell Dev Biol | 2023 | 38054182 | PubTator, text mining | PubMed |
| Hydrothermal dewatering of low-grade coal: Product evaluation and primary component analysis of ash deposition. | Heliyon | 2023 | 38045174 | PubTator, text mining | PubMed |
| Impact of NAD+ metabolism on ovarian aging. | Immun Ageing | 2023 | 38041117 | PubTator, text mining | PubMed |
| Potassium ion pre-intercalated MnO2 for aqueous multivalent ion batteries. | Front Optoelectron | 2023 | 38038763 | PubTator, text mining | PubMed |
| Validation of Chinese version of the 5-item WHO well-being index in type 2 diabetes mellitus patients. | BMC Psychiatry | 2023 | 38031007 | PubTator, text mining | PubMed |
| Suppression of Kynurenine 3-Monooxygenase as a Treatment for Triple-negative Breast Carcinoma. | Anticancer Res | 2023 | 38030171 | PubTator, text mining | PubMed |
| A bronchial gene signature specific for severe COPD that is retained in the nose. | ERJ Open Res | 2023 | 38020574 | PubTator, text mining | PubMed |
| A mechanistic insight into severe COPD: the nose as a surrogate for the airways. | ERJ Open Res | 2023 | 38020557 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8564/papers?page=8